The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List

Slideshow IPOs

By The Online Investor Staff, updated Fri., Dec. 19, 6:23 PM

Slide #1. PlasmaTech Biopharmaceuticals, Inc. Initial Public Offering

Company: PlasmaTech Biopharmaceuticals, Inc.
Proposed Symbol: PTBI
Shares Offered: 3,500,000
Description: PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI, PTBIW), a biopharmaceutical company advancing patient care in critical areas, announced the pricing of an underwritten public offering of 3,500,000 shares of common stock, and warrants to purchase up to an aggregate 3,500,000 shares of common stock, at an offering price of $4.00 per share and $.01 per warrant. The warrants have a per share exercise price of $5.00, are exercisable immediately, and expire 5 years from the date of issuance. The shares and warrants will begin trading on The NASDAQ Capital Market on December 19, 2014 under the symbols "PTBI" and "PTBIW," respectively.

IPOs: PlasmaTech Biopharmaceuticals, Inc.

List of IPOs in this Slideshow:
Company                                 Ticker    IPO Date
Neothetics                              NEOT      
Neff Corporation                        NEFF      
Peak Resorts                            SKIS      
Avolon Holdings Limited                 AVOL      
Great Ajax Corp                         T.B.D.    
OnCore Biopharma, Inc.                  T.B.D.    
Histogenics Corporation                 HSGX      
Momo Inc.                               MOMO      
Rice Midstream Partners LP              RMP       
James River Group Holdings, Ltd.        JRVR      
Metaldyne Performance Group Inc.        MPG       
CB Pharma Acquisition Corp.             CNLMU     
Patriot National, Inc.                  T.B.D.    
Medovex Corp.                           MDVX      
PlasmaTech Biopharmaceuticals, Inc.     PTBI      

December 19, 2014    6:23 PM Eastern

IPOs | | Copyright © 1998 - 2014, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.